Agenda | August 19, 1-2.30pm
In this session of the learning series, we heard about pregnancy and postpartum SUD treatment from clinicians working to provide compassionate, high-quality care. The webinar featured:
- Promise to HOPE, Miami Valley Hospital with David McKenna
- TriHealth HOPE Program with Michael Marcotte
- UNC Horizons with Hendrée Jones and Elisabeth Johnson
- Chemically Using Pregnant Women’s Program, Swedish Medical Center with Vania Rudolf
Explore materials from this session
David S. McKenna, MD, RDMS, FACOG is a graduate of Case Western Reserve University School of Medicine in Cleveland Ohio. He completed his residency in Obstetrics and Gynecology with the U.S. Air Force at Wright Patterson AFB and Wright State University in Dayton, Ohio, and fellowship training in Maternal-Fetal Medicine at The Ohio State University in Columbus, Ohio. He was on active duty in the U.S. Air Force for 16 years and on the faculty at Wright State University for six years, attaining the ranks of Lt. Colonel and Associate Professor. After leaving the Air Force, he worked for one year at the Mountain Area Health Education Center in Asheville North Carolina and returned to Dayton in 2005.
Michael Marcotte, MD is a Maternal Fetal Medicine provider at TriHealth, one of the largest Health systems in Ohio. For the last 10 years, his clinical work has focused on pregnancy and substance use disorder. Dr. Marcotte became board certified in addiction medicine in 2019. He serves as the medical director for TriHealth’s prenatal program for women with substance use disorder (HOPE), which serves over 500 pregnant women with substance use disorder per year. He is also the medical director for First Step Home, a residential treatment program for women with substance use disorders and their children, where he also runs an office-based treatment program. Dr. Marcotte is also a clinical OB lead for The Ohio Perinatal Quality Collaborative (OPQC), which currently has three projects working to spread best practices for smoking cessation interventions in pregnancy, caring for pregnant women with opiate use disorders and a multi-pronged approach to prevention of preterm birth.
Hendrée Jones, PhD is the Executive Director of UNC Horizons and professor in the UNC Department of Obstetrics and Gynecology. Dr. Jones is an internationally recognized expert in the development and examination of both behavioral and pharmacologic treatments for pregnant women and their children in risky life situations. She has received continuous National Institutes of Health funding since 1994 and has written more than 195 publications. Dr. Jones has also authored two books, one on treating patients for substance use disorders and the other on comprehensive care for women who are pregnant and have substance use disorders. She also has written multiple textbook chapters on the topic of pregnancy and addiction. While winning multiple awards, most recently in 2020 Dr. Jones won the American Society of Addiction Medicine (ASAM) R. Brinkley Smithers and Distinguished Scientist Award. She is a consultant for the United Nations and the World Health Organization.
Elisabeth Johnson, PhD, FNP-BC is a clinical assistant professor in the UNC Department of Obstetrics and Gynecology. She is also the Director of Health Services for UNC Horizons, a comprehensive substance use disorder treatment center for pregnant and parenting women and their children. As a nurse practitioner, she has over twenty years of clinical experience in women’s health and pediatrics, including caring for women with substance use disorders. Her current clinical practice consists primarily of providing obstetric care to women with substance use disorders, many of whom are on opioid agonist therapy. Dr. Johnson has collaborated on several research projects in the areas of chronic pain and substance use disorders and provided valuable clinical expertise to the 2018 SAMHSA publication entitled, Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants.